MRK
Merck & Co., Inc.
NYSE · Healthcare · Drug Manufacturers - General · US
$146.76
−0.27%Leverage
- Debt / equity
- 1.29x
- Net debt / equity
- 1.12x
- Debt / assets
- 0.42x
- Debt / EBITDA
- 3.89x
- Net debt / EBITDA
- 3.40x
Liquidity & coverage
- Current ratio
- 1.32x
- Quick ratio
- 1.10x
- Cash ratio
- 0.26x
- Interest coverage
- 8.75x
- EBITDA / interest
- 10.96x
- Working capital
- $8.9B
Cash & dividend
- FCF / debt
- 0.30x
- Cash flow / debt
- 0.37x
- Dividend per share
- $3.40
- Dividend yield
- 2.3%
- Dividend growth 1y
- +5.1%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026